Nautilus Biotechnology, Inc. (NAUT)
NASDAQ: NAUT · Real-Time Price · USD
0.8487
-0.0318 (-3.61%)
Aug 18, 2026, 11:29 AM EDT - Market open
Nautilus Biotechnology Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Nautilus Biotechnology stock have an average target of $4.00, which predicts a 371.31% increase from the current stock price of 0.85.
Price Target: $4.00 (+371.31%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Nautilus Biotechnology stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Dec '25 | Jan '26 | Feb '26 | Apr '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Buy Reiterates $4 | Buy | Reiterates | $4 | +371.31% | Jul 29, 2026 |
| TD Cowen | TD Cowen | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Apr 28, 2026 |
Financial Forecast
Revenue This Year
500.00K
Revenue Next Year
6.10M
from 500.00K
Increased by 1,120.00%
EPS This Year
-0.61
EPS Next Year
-0.60
from -0.61
EPS and Forward PE are based on non-GAAP adjusted numbers.